Bristol Myers Squibb (BMY) — Entry Risk Score

Stock · re-scored every trading day · data as of 2026-11-12

84
on a 30–98 scale
BUY
$62.32last close
+2score vs prior day
53–96range since 06-30
+8.2%price since 06-30

The entry score measures one thing: how far Bristol Myers Squibb's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.

On 2026-11-12, Bristol Myers Squibb's price sits 0.25 ATR above its 20-day average ($61.89); it trades above its 200-day average ($60.30); its 14-day RSI is 54; it has moved +4.3% over 20 sessions; our regime filter classifies it as no confirmed trend.

Is Bristol Myers Squibb (BMY) a buy right now?

Bristol Myers Squibb scores 84/98 (Buy) as of 2026-11-12; it is 8.5% below its 52-week high of $68.09; it is above its 200-day average; it moved +0.29% over the last 5 sessions. A high score means our model rates today's price as a favorable, defined-risk entry, based on where it sits versus its 20-day average after adjusting for trend and volatility. It is not a prediction that the price will rise. Not investment advice.

Score history

80 60

Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.

DateScoreΔClose
2026-11-1284+2$62.32
2026-11-0682+3$62.14
2026-11-0579+10$63.13
2026-11-0469-12$64.19
2026-11-0381+8$61.71
2026-11-0273-8$63.02
2026-10-2981-5$61.39
2026-10-2886+3$60.57
2026-10-2783+2$61.55
2026-10-2681-3$61.61
2026-10-2384+9$61.48
2026-10-2275-10$63.00

Related stocks

See today's full rankings + entry plan for BMY →

Get the Sunday Brief

One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.